24 March 2018 in Journal of Biomolecular Structure and Dynamics
Antimicrobial peptides (AMPs) play crucial role as mediators of the primary host defense against microbial invasion. They are considered a promising alternative to antibiotics for multidrug resistant bacterial strains. For complete understanding of the antimicrobial defense mechanism, a detailed knowledge of the dynamics of peptide-membrane interactions, including atomistic studies on AMPs geometry and both peptide and membrane structural changes during the whole process is a prerequisite. We aim at clarifying the conformation dynamics of small linear AMPs in solution as a first step of in silico protocol for establishing a correspondence between certain amino-acid sequence motifs, secondary-structure elements, conformational dynamics in solution and the intensity and mode of interaction with the bacterial membrane. To this end, we use molecular dynamics simulations augmented by well-tempered metadynamics to study the free-energy landscape of two AMPs with close primary structure and different antibacterial activity – the native magainin 2 (MG2) and an analog (MG2m, with substitutions F5Y and F16W) in aqueous solution. We observe that upon solvation, the initial α-helical structures change differently. The native form remains structured, with three shorter α-helical motifs, connected by random coils, while the synthetic analog tends predominantly to a disordered conformation. Our results indicate the importance of the side-chains at positions 5 and 16 for maintaining the solvated peptide conformation. They also provide a modeling background for recent experimental observations, relating the higher α-helical content in solution (peptide pre-folding) in the case of small linear AMPs to a lower antibacterial activity.
17 July 2025 in Biochemical and Biophysical Research Communications
Antimicrobial peptides (AMPs) are seen as a promising alternative to conventional antibiotics, yet their mechanism of action is not fully understood. We recently proposed that AMPs do not act as isolated monomers but instead aggregate into nano-sized clusters before targeting the membrane. However, cationic peptides may struggle to form clusters large enough to achieve effective membrane disruption alone, suggesting the involvement of a co-actor in this process. Here, we tackle this issue through both in silico and in vitro studies of mono- and bicomponent solutions comprising two newly identified peptides, one charged and the other neutral, before the interaction with the target membrane. We observe that while the charged peptides alone do not form clusters of noticeable size, in the mixture with the neutral peptides they coalesce into layered aggregates with a hydrophobic core of the neutral moiety and the charged monomers exposed to the surrounding solvent. The size of these mixed charged/neutral peptides aggregates is smaller than the ones in the neutral monocomponent solution due to the counteraction of electrostatic repulsion to the hydrophobic effect. We regard the structures thus formed as an ideal transport system - locking hydrophobic uncharged residues in the cluster core prevents interaction with eukaryotic membranes, while solvent-exposed charged residues facilitate electrostatic interaction with bacterial surfaces.